Stress Testing and Cardiac Magnetic Resonance

• Status: Completed
• Trial end date: 2014-06-04
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to better define the role of a comprehensive stress MRI (which includes myocardial perfusion imaging, optimized coronary imaging, and myocardial scar imaging) in medical practice and in patient health management. Information gathered from the healthy volunteers that participate in this study will be compared to information from the coronary artery disease patients in this study in order to help further our understanding.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Chicago
• Collaborator: Astellas Pharma Inc
• Treatments: Regadenoson

Criteria

Inclusion Criteria:

• Suspected coronary artery disease

• Symptoms of possible coronary artery disease

Exclusion Criteria:

• Acute ST-elevation myocardial infarction

• Second or third degree AV block

• Severe Renal Disease (Glomerular Filtration Rate (GFR) <30cc/min or hemodialysis)

• Contra-indications to MRI (i.e. Implantable Cardioverter Defibrillator (ICD), pacemaker, aneurysm clip, etc)

• Hemodynamic instability

• Inability to provide informed consent

• Severe claustrophobia

• Pregnancy

• Age <18 years